Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis

There is no satisfactory medical treatment for patients with primary sclerosing cholangitis. There are conflicting data regarding the clinical benefit of high doses of ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis.To evaluate using meta-analysis, if UDCA (standard or high-dose) is useful in primary sclerosing cholangitis.We searched MEDLINE using the textwords 'PSC', 'treatment', 'UDCA' and retrieved all abstracts from the major...